Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2017/08/18 00:44:54」(JST)

wiki en

During the activation of lymphocytes, co-stimulation is often crucial to the development of an effective immune response. Co-stimulation is required in addition to the antigen-specific signal from their antigen receptors.^[1]

T Cell Co-stimulation

T cells require two signals to become fully activated. A first signal, which is antigen-specific, is provided through the T cell receptor or TCR which interacts with peptide-MHC molecules on the membrane of antigen presenting cells (APC). A second signal, the co-stimulatory signal, is antigen nonspecific and is provided by the interaction between co-stimulatory molecules expressed on the membrane of APC and the T cell.

One of the best characterized co-stimulatory molecules expressed by T cells is CD28, which interacts with CD80 (B7.1) and CD86 (B7.2) on the membrane of APC. Another costimulatory receptor expressed by T cells is ICOS ( Inducible Costimulator), which interacts with ICOS-L.

T cell co-stimulation is necessary for T cell proliferation, differentiation and survival. Activation of T cells without co-stimulation may lead to T cell anergy, T cell deletion or the development of immune tolerance.

B Cell Co-stimulation

B cell binds antigens with its BCR (a membrane-bound antibody), which transfers intracellular signals to the B cell as well as inducing the B cell to engulf the antigen, process it, and present it on the MHC II molecules.^[2] The latter case induces recognition by antigen-specific Th2 cells, leading to activation of the B cell through binding of TCR to the MHC-antigen complex. It is followed by synthesis and presentation of CD40L (CD154) on the Th2 cell, which binds to CD40 on the B cell, thus the Th2 cell can co-stimulate the B cell.^[3] Without this co-stimulation the B cell cannot proliferate further. ^[4]

Co-stimulation for B cells is provided alternatively by complement receptors. Microbes may activate the complement system directly and complement component C3b bind to microbes. After C3b is degraded into a fragment iC3b (inactive derivative of C3b), then cleaved to C3dg, and finally to C3d, which continue to bind to microbal surface, B cells express complement receptor CR2 (CD21) to bind to iC3b, C3dg, or C3d.^[5] This additional binding makes the B cells 100- to 10,000-fold more sensitive to antigen.^[6] CR2 on mature B cells forms a complex with CD19 and CD81. This complex is called the B cell coreceptor complex for such sensitivity enhancement to the antigen.^[7]

Applications

Abatacept (Orencia) is a T cell co-stimulation modulator approved for the treatment of rheumatoid arthritis. The cytokines secreted by activated T cells are thought to both initiate and propagate the immunologically driven inflammation associated with rheumatoid arthritis. Orencia, a soluble fusion protein, works by altering the co-stimulatory signal required for full T-cell activation. Belatacept is another novel molecule which is being tested for use in renal transplantation.

A new co-stimulatory superagonistic drug, TGN1412, was the subject of a clinical trial at Northwick Park Hospital, London. The trial became surrounded in controversy as the six volunteers became seriously ill within minutes of being given the drug.

In essence, the co-stimulatory molecules function as "flashing red lights" that interact with the T cell, communicating that the material being presented by the dendritic cell material indicates danger. Dendritic cells displaying co-stimulatory molecules while presenting antigen are able to activate T cells. In contrast, T cells that recognize antigen presented by a dendritic cell not displaying co-stimulatory molecules are generally driven to apoptosis, or may become unresponsive to future encounters with the antigen.

References

^ Seda, V; Mraz, M (2014). "B cell receptor (BCR) signalling and its crosstalk with other pathways in normal and malignant cells". European Journal of Haematology. 94: 193–205. PMID 25080849. doi:10.1111/ejh.12427.
^ Seda, V; Mraz, M (2014). "B cell receptor (BCR) signalling and its crosstalk with other pathways in normal and malignant cells". European Journal of Haematology. 94: 193–205. PMID 25080849. doi:10.1111/ejh.12427.
^ Janeway CA, Travers P, Walport M, Shlomchik M (2001). Immunobiology 5 : The Immune System in Health and Disease, 5th ed. New York: Garland Pub., ISBN 0-8153-3642-X
^ Noelle, R. J.; Roy, M.; Shepherd, D. M.; Stamenkovic, I.; Ledbetter, J. A.; Aruffo, A. (1992). "A 39-kDa protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells". Proceedings of the National Academy of Sciences of the United States of America. 89 (14): 6550–6554. PMC 49539 . PMID 1378631. doi:10.1073/pnas.89.14.6550.
^ Frank K, Atkinson JP (2001). "Complement system." In Austen KF, Frank K, Atkinson JP, Cantor H. eds. Samter's Immunologic Diseases, 6th ed. Vol. 1, p. 281–298, Philadelphia: Lippincott Williams & Wilkins, ISBN 0-7817-2120-2
^ Dempsey, P. W.; Allison, M. E.; Akkaraju, S.; Goodnow, C. C.; Fearon, D. T. (1996). "C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity". Science. 271 (5247): 348–350. PMID 8553069. doi:10.1126/science.271.5247.348.
^ Abbas AK, Lichtman AH (2003). Cellular and Molecular Immunology, 5th ed. Philadelphia: Saunders, ISBN 0-7216-0008-5.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 関節リウマチの病因 pathogenesis of rheumatoid arthritis
2. 造血細胞移植後の移植片対腫瘍効果の生物学 biology of the graft versus tumor effect following hematopoietic cell transplantation
3. 移植免疫 transplantation immunobiology
4. 関節リウマチのT細胞標的療法 t cell targeted therapies for rheumatoid arthritis
5. 移植片対宿主病の病因 pathogenesis of graft versus host disease

English Journal

T follicular regulatory cells.

Sage PT1,2, Sharpe AH1,2,3.
Immunological reviews.Immunol Rev.2016 May;271(1):246-59. doi: 10.1111/imr.12411.
Pathogen exposure elicits production of high-affinity antibodies stimulated by T follicular helper (Tfh) cells in the germinal center reaction. Tfh cells provide both costimulation and stimulatory cytokines to B cells to facilitate affinity maturation, class switch recombination, and plasma cell dif
PMID 27088919

Development of T-cell tolerance utilizes both cell-autonomous and cooperative presentation of self-antigen.

Perry JS1, Hsieh CS1.
Immunological reviews.Immunol Rev.2016 May;271(1):141-55. doi: 10.1111/imr.12403.
The development of T-cell self-tolerance in the thymus is important for establishing immune homeostasis and preventing autoimmunity. Here, we review the components of T-cell tolerance, which includes T-cell receptor (TCR) self-reactivity, costimulation, cytokines, and antigen presentation by a varie
PMID 27088912

ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution.

Oshima S1, Karrer EE2, Paidhungat MM3, Neighbors M4, Chapin SJ4, Fan RA4, Reed MA4, Wu K4, Wong C4, Chen Y5, Whitlow M6, Anderson FA3, Bam RA3, Zhang Q3, Larsen BR5, Viswanathan S7, Devens BH4, Bass SH3, Higashi Y8.
Protein engineering, design & selection : PEDS.Protein Eng Des Sel.2016 May;29(5):159-67. doi: 10.1093/protein/gzw002. Epub 2016 Mar 10.
The CTLA4-Ig therapeutics abatacept and belatacept inhibit CD28-mediated T cell activation by binding CD80 (B7-1) and CD86 (B7-2) co-stimulatory ligands. Both compounds preferentially bind CD80, yet CD86 has been implicated as the dominant co-stimulatory ligand. Using directed evolution methods, nov
PMID 26968452